Advertisement

Index by author

November 01, 1993; Volume 21,Issue 6

A

  1. Abbott, F

    1. In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid.
      K Kassahun and F Abbott
      Drug Metabolism and Disposition November 1993, 21 (6) 1098-1106;

  2. Adusumalli, V E

    1. Distribution of the anticonvulsant felbamate to cerebrospinal fluid and brain tissue of adult and neonatal rats.
      V E Adusumalli, J K Wichmann, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition November 1993, 21 (6) 1079-1085;

  3. Alberts, D W

    1. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;

  4. Andoh, K

    1. Pharmacokinetic study of p-chloronitrobenzene in humans suffering from acute poisoning.
      T Yoshida, T Tabuchi and K Andoh
      Drug Metabolism and Disposition November 1993, 21 (6) 1142-1146;

B

  1. Baba, T

    1. Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;

  2. Baker, M T

    1. Inhibitory effects of deuterium substitution on the metabolism of sevoflurane by the rat.
      M T Baker, W C Ronnenberg, J A Ruzicka, C K Chiang and J H Tinker
      Drug Metabolism and Disposition November 1993, 21 (6) 1170-1171;

  3. Bandyopadhyay, A M

    1. Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;

  4. Barrow, A

    1. Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;

  5. Bekersky, I

    1. Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.
      I Bekersky, R J Puhl, G Hanson and S Mong
      Drug Metabolism and Disposition November 1993, 21 (6) 1017-1021;

  6. Berger, Y

    1. Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
      G Fabre, B Julian, B Saint-Aubert, H Joyeux and Y Berger
      Drug Metabolism and Disposition November 1993, 21 (6) 978-985;

  7. Bertin, D

    1. In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;

  8. Bishop, J B

    1. Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
      W Zheng, S M Winter, M Mayersohn, J B Bishop and I G Sipes
      Drug Metabolism and Disposition November 1993, 21 (6) 1091-1097;

  9. Black, A

    1. Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;

  10. Blouin, R A

    1. Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;

  11. Bogdanffy, M S

    1. Kinetics of nasal carboxylesterase-mediated metabolism of vinyl acetate.
      M S Bogdanffy and M L Taylor
      Drug Metabolism and Disposition November 1993, 21 (6) 1107-1111;

  12. Bolton, M G

    1. Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;

  13. Boutin, J A

    1. In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;

  14. Brouwer, K L

    1. Acute phenobarbital administration alters the disposition of acetaminophen metabolites in the rat.
      K L Brouwer
      Drug Metabolism and Disposition November 1993, 21 (6) 1129-1133;

C

  1. Castle, M C

    1. Formation of a beta-glucuronidase-resistant glucuronide conjugate of digitoxin by dog liver microsomes.
      M C Castle
      Drug Metabolism and Disposition November 1993, 21 (6) 1147-1150;

  2. Chang, T

    1. Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;

  3. Chauret, N

    1. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;

  4. Chiang, C K

    1. Inhibitory effects of deuterium substitution on the metabolism of sevoflurane by the rat.
      M T Baker, W C Ronnenberg, J A Ruzicka, C K Chiang and J H Tinker
      Drug Metabolism and Disposition November 1993, 21 (6) 1170-1171;

  5. Chui, Y C

    1. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;

  6. Chung, J G

    1. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
      J G Chung, G N Levy and W W Weber
      Drug Metabolism and Disposition November 1993, 21 (6) 1057-1063;

  7. Coddington, A B

    1. Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
      L E Los, A B Coddington, H G Ramjit and H D Colby
      Drug Metabolism and Disposition November 1993, 21 (6) 1086-1090;

  8. Coe, R A

    1. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;

  9. Colby, H D

    1. Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
      L E Los, A B Coddington, H G Ramjit and H D Colby
      Drug Metabolism and Disposition November 1993, 21 (6) 1086-1090;

  10. Colthup, P V

    1. Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;

  11. Colvin, O M

    1. Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;

D

  1. Drey, J M

    1. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;

  2. Duggan, D E

    1. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;

F

  1. Fabre, G

    1. Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
      G Fabre, B Julian, B Saint-Aubert, H Joyeux and Y Berger
      Drug Metabolism and Disposition November 1993, 21 (6) 978-985;

  2. Farinotti, R

    1. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
      C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti
      Drug Metabolism and Disposition November 1993, 21 (6) 1125-1128;

  3. Feng, R

    1. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;

  4. Fernandez, C

    1. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
      C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti
      Drug Metabolism and Disposition November 1993, 21 (6) 1125-1128;

  5. Fujioka, M

    1. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

  6. Fujita, S

    1. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
      Y Masubuchi, N Kagimoto, S Narimatsu, S Fujita and T Suzuki
      Drug Metabolism and Disposition November 1993, 21 (6) 1012-1016;

  7. Fujitsu, T

    1. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

G

  1. Gilbert, P J

    1. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;

  2. Gimenez, F

    1. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
      C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti
      Drug Metabolism and Disposition November 1993, 21 (6) 1125-1128;

  3. Gires, P

    1. Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
      A Sabouraud, M Redureau, P Gires, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition November 1993, 21 (6) 997-1002;

  4. Gonzalez, F J

    1. Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;

  5. Grossman, S J

    1. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;

  6. Guengerich, F P

    1. Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;

H

  1. Halpin, R A

    1. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;

  2. Hamilton, R

    1. Relationship between the terminal disposition half-life and mean residence time in multicompartment models.
      M Mayersohn and R Hamilton
      Drug Metabolism and Disposition November 1993, 21 (6) 1172-1173;

  3. Hanson, G

    1. Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.
      I Bekersky, R J Puhl, G Hanson and S Mong
      Drug Metabolism and Disposition November 1993, 21 (6) 1017-1021;

  4. Hartley, T E

    1. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;

  5. Hendrickx, J

    1. Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;

  6. Hennig, P

    1. In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;

  7. Herold, E G

    1. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;

  8. Heykants, J

    1. Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;

  9. Hillbeck, D

    1. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;

  10. Hilton, J

    1. Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;

  11. Huang, M L

    1. Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;

  12. Hunninghake, D B

    1. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;

I

  1. Inui, Y

    1. Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;

  2. Iwasaki, K

    1. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

J

  1. Jarman, M

    1. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;

  2. Joyeux, H

    1. Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
      G Fabre, B Julian, B Saint-Aubert, H Joyeux and Y Berger
      Drug Metabolism and Disposition November 1993, 21 (6) 978-985;

  3. Julian, B

    1. Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
      G Fabre, B Julian, B Saint-Aubert, H Joyeux and Y Berger
      Drug Metabolism and Disposition November 1993, 21 (6) 978-985;

K

  1. Kagimoto, N

    1. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
      Y Masubuchi, N Kagimoto, S Narimatsu, S Fujita and T Suzuki
      Drug Metabolism and Disposition November 1993, 21 (6) 1012-1016;

  2. Kari, P H

    1. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;

  3. Kassahun, K

    1. In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid.
      K Kassahun and F Abbott
      Drug Metabolism and Disposition November 1993, 21 (6) 1098-1106;

  4. Kucharczyk, N

    1. Distribution of the anticonvulsant felbamate to cerebrospinal fluid and brain tissue of adult and neonatal rats.
      V E Adusumalli, J K Wichmann, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition November 1993, 21 (6) 1079-1085;

  5. Kulkarni, S

    1. Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;

L

  1. Lambert, P H

    1. In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;

  2. Lee, H

    1. Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;

  3. Levy, G N

    1. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
      J G Chung, G N Levy and W W Weber
      Drug Metabolism and Disposition November 1993, 21 (6) 1057-1063;

  4. Lłnning, P E

    1. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;

  5. Los, L E

    1. Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
      L E Los, A B Coddington, H G Ramjit and H D Colby
      Drug Metabolism and Disposition November 1993, 21 (6) 1086-1090;

M

  1. Maconochie, J G

    1. Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;

  2. Manchee, G R

    1. Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;

  3. Mannens, G

    1. Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;

  4. Maradeix, V

    1. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
      C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti
      Drug Metabolism and Disposition November 1993, 21 (6) 1125-1128;

  5. Martinet, M

    1. Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
      A Sabouraud, M Redureau, P Gires, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition November 1993, 21 (6) 997-1002;

  6. Masubuchi, Y

    1. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
      Y Masubuchi, N Kagimoto, S Narimatsu, S Fujita and T Suzuki
      Drug Metabolism and Disposition November 1993, 21 (6) 1012-1016;

  7. Mather, L E

    1. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;

  8. Mayersohn, M

    1. Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
      W Zheng, S M Winter, M Mayersohn, J B Bishop and I G Sipes
      Drug Metabolism and Disposition November 1993, 21 (6) 1091-1097;
    2. Relationship between the terminal disposition half-life and mean residence time in multicompartment models.
      M Mayersohn and R Hamilton
      Drug Metabolism and Disposition November 1993, 21 (6) 1172-1173;

  9. McCague, R

    1. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;

  10. McClain, C J

    1. Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;

  11. McLean, C F

    1. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;

  12. McNally, W

    1. Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;

  13. Meuldermans, W

    1. Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;

  14. Meunier, F

    1. In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;

  15. Milne, R W

    1. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;

  16. Mimura, M

    1. Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;

  17. Mong, S

    1. Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.
      I Bekersky, R J Puhl, G Hanson and S Mong
      Drug Metabolism and Disposition November 1993, 21 (6) 1017-1021;

  18. Mulder, G J

    1. Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
      Y Zhao, C A Snel, G J Mulder and K S Pang
      Drug Metabolism and Disposition November 1993, 21 (6) 1070-1078;

N

  1. Nagase, K

    1. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

  2. Nakatsuka, I

    1. Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist.
      M Yabuki, F Shono, I Nakatsuka and A Yoshitake
      Drug Metabolism and Disposition November 1993, 21 (6) 1167-1169;

  3. Narimatsu, S

    1. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
      Y Masubuchi, N Kagimoto, S Narimatsu, S Fujita and T Suzuki
      Drug Metabolism and Disposition November 1993, 21 (6) 1012-1016;

  4. Nation, R L

    1. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;

  5. Nicoll-Griffith, D

    1. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;

  6. Noda, K

    1. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

  7. Noe, D A

    1. Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;

O

  1. Ohmori, S

    1. Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;

  2. Oxford, J

    1. Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;

P

  1. Palmer, E

    1. Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;

  2. Pang, K S

    1. Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
      Y Zhao, C A Snel, G J Mulder and K S Pang
      Drug Metabolism and Disposition November 1993, 21 (6) 1070-1078;

  3. Patrick, D H

    1. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;

  4. Poon, G K

    1. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;

  5. Puhl, R J

    1. Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.
      I Bekersky, R J Puhl, G Hanson and S Mong
      Drug Metabolism and Disposition November 1993, 21 (6) 1017-1021;

R

  1. Ramjit, H G

    1. Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
      L E Los, A B Coddington, H G Ramjit and H D Colby
      Drug Metabolism and Disposition November 1993, 21 (6) 1086-1090;

  2. Redureau, M

    1. Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
      A Sabouraud, M Redureau, P Gires, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition November 1993, 21 (6) 997-1002;

  3. Robertson, K D

    1. Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;

  4. Ronnenberg, W C

    1. Inhibitory effects of deuterium substitution on the metabolism of sevoflurane by the rat.
      M T Baker, W C Ronnenberg, J A Ruzicka, C K Chiang and J H Tinker
      Drug Metabolism and Disposition November 1993, 21 (6) 1170-1171;

  5. Rowlands, M G

    1. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;

  6. Runciman, W B

    1. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;

  7. Rutten, A J

    1. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;

  8. Ruzicka, J A

    1. Inhibitory effects of deuterium substitution on the metabolism of sevoflurane by the rat.
      M T Baker, W C Ronnenberg, J A Ruzicka, C K Chiang and J H Tinker
      Drug Metabolism and Disposition November 1993, 21 (6) 1170-1171;

S

  1. Sabouraud, A

    1. Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
      A Sabouraud, M Redureau, P Gires, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition November 1993, 21 (6) 997-1002;

  2. Saint-Aubert, B

    1. Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
      G Fabre, B Julian, B Saint-Aubert, H Joyeux and Y Berger
      Drug Metabolism and Disposition November 1993, 21 (6) 978-985;

  3. Sakuma, S

    1. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

  4. Sato, A

    1. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

  5. Scherrmann, J M

    1. Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
      A Sabouraud, M Redureau, P Gires, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition November 1993, 21 (6) 997-1002;

  6. Serkiz, B

    1. In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;

  7. Shedlofsky, S I

    1. Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;

  8. Shimada, T

    1. Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;

  9. Shimatani, K

    1. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

  10. Shiraga, T

    1. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

  11. Shono, F

    1. Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist.
      M Yabuki, F Shono, I Nakatsuka and A Yoshitake
      Drug Metabolism and Disposition November 1993, 21 (6) 1167-1169;

  12. Shum, Y Y

    1. Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;

  13. Sipes, I G

    1. Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
      W Zheng, S M Winter, M Mayersohn, J B Bishop and I G Sipes
      Drug Metabolism and Disposition November 1993, 21 (6) 1091-1097;

  14. Sloan, P A

    1. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;

  15. Snel, C A

    1. Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
      Y Zhao, C A Snel, G J Mulder and K S Pang
      Drug Metabolism and Disposition November 1993, 21 (6) 1070-1078;

  16. Sofia, R D

    1. Distribution of the anticonvulsant felbamate to cerebrospinal fluid and brain tissue of adult and neonatal rats.
      V E Adusumalli, J K Wichmann, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition November 1993, 21 (6) 1079-1085;

  17. Somogyi, A A

    1. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;

  18. Streeper, R T

    1. Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;

  19. Suzuki, T

    1. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
      Y Masubuchi, N Kagimoto, S Narimatsu, S Fujita and T Suzuki
      Drug Metabolism and Disposition November 1993, 21 (6) 1012-1016;

T

  1. Tabuchi, T

    1. Pharmacokinetic study of p-chloronitrobenzene in humans suffering from acute poisoning.
      T Yoshida, T Tabuchi and K Andoh
      Drug Metabolism and Disposition November 1993, 21 (6) 1142-1146;

  2. Tarbit, M H

    1. Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;

  3. Taylor, M L

    1. Kinetics of nasal carboxylesterase-mediated metabolism of vinyl acetate.
      M S Bogdanffy and M L Taylor
      Drug Metabolism and Disposition November 1993, 21 (6) 1107-1111;

  4. Thuillier, A

    1. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
      C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti
      Drug Metabolism and Disposition November 1993, 21 (6) 1125-1128;

  5. Till, A E

    1. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;

  6. Tinker, J H

    1. Inhibitory effects of deuterium substitution on the metabolism of sevoflurane by the rat.
      M T Baker, W C Ronnenberg, J A Ruzicka, C K Chiang and J H Tinker
      Drug Metabolism and Disposition November 1993, 21 (6) 1170-1171;

  7. Toler, S M

    1. Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;

  8. Tozuka, Z

    1. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

  9. Troke, J A

    1. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;

  10. Turcan, R G

    1. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;

U

  1. Ulm, E H

    1. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;

  2. Umbenhauer, D R

    1. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;

V

  1. Volland, J P

    1. In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;

  2. Vose, C W

    1. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;

  3. Vyas, K P

    1. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;

W

  1. Weber, W W

    1. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
      J G Chung, G N Levy and W W Weber
      Drug Metabolism and Disposition November 1993, 21 (6) 1057-1063;

  2. Wichmann, J K

    1. Distribution of the anticonvulsant felbamate to cerebrospinal fluid and brain tissue of adult and neonatal rats.
      V E Adusumalli, J K Wichmann, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition November 1993, 21 (6) 1079-1085;

  3. Winter, S M

    1. Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
      W Zheng, S M Winter, M Mayersohn, J B Bishop and I G Sipes
      Drug Metabolism and Disposition November 1993, 21 (6) 1091-1097;

  4. Woestenborghs, R

    1. Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;

  5. Woolf, T F

    1. Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;

Y

  1. Yabuki, M

    1. Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist.
      M Yabuki, F Shono, I Nakatsuka and A Yoshitake
      Drug Metabolism and Disposition November 1993, 21 (6) 1167-1169;

  2. Yamazaki, H

    1. Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;

  3. Yergey, J A

    1. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;

  4. Yoshida, T

    1. Pharmacokinetic study of p-chloronitrobenzene in humans suffering from acute poisoning.
      T Yoshida, T Tabuchi and K Andoh
      Drug Metabolism and Disposition November 1993, 21 (6) 1142-1146;

  5. Yoshitake, A

    1. Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist.
      M Yabuki, F Shono, I Nakatsuka and A Yoshitake
      Drug Metabolism and Disposition November 1993, 21 (6) 1167-1169;

  6. Young, A B

    1. Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;

Z

  1. Zhao, Y

    1. Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
      Y Zhao, C A Snel, G J Mulder and K S Pang
      Drug Metabolism and Disposition November 1993, 21 (6) 1070-1078;

  2. Zheng, W

    1. Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
      W Zheng, S M Winter, M Mayersohn, J B Bishop and I G Sipes
      Drug Metabolism and Disposition November 1993, 21 (6) 1091-1097;
Back to top

In this issue